Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 24Terminated 7Unknown 4Active not recruiting 4Recruiting 3Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 3NIH 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

CNS 4

Conditions

Brain Neoplasms 264Glioblastoma 193Glioma 159Neuroblastoma 56Central Nervous System Neoplasms 55Astrocytoma 45Carcinoma, Non-Small-Cell Lung 39Neoplasms 32Breast Neoplasms 27Oligodendroglioma 26Meningioma 23Recurrence 21Neuroma, Acoustic 21Neoplasm Metastasis 20Meningeal Carcinomatosis 20Gliosarcoma 20Neurofibromatosis 1 18Medulloblastoma 18Lung Neoplasms 15Paraganglioma 14Lymphoma 14Pheochromocytoma 13Spinal Cord Neoplasms 12Sarcoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Burkitt Lymphoma 9Pancreatic Neoplasms 8Ovarian Neoplasms 7Melanoma 7Esophageal Neoplasms 7

Interventions

Bevacizumab 189Zr-bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Neurofibromatosis 2 × CNS × Clear all
NCT05685836 2024-03-20

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Leiden University Medical Center

Unknown
15 enrolled
CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT04890132 2023-03-16

Vestibular Precision: Physiology & Pathophysiology

Massachusetts Eye and Ear Infirmary

Phase NA Unknown
90 enrolled
CNS

Dizziness, Labyrinth Diseases, Neuroma, Acoustic, Vestibular Diseases, Neurofibromatosis 2

NCT03893643 2019-03-28

Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15

Centre Hospitalier Universitaire de Nice

Unknown
1,000 enrolled
CNS

Neurofibromatosis 2

NCT00004483 2005-09-29

NF2 Natural History Consortium

Office of Rare Diseases (ORD)

Unknown
100 enrolled
CNS

Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡